Scribe Therapeutics Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Scribe Therapeutics Inc. now
Current reporting with the operating signal separated from the noise.
Scribe Therapeutics Inc.: Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
Scribe Therapeutics Inc.: Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
The story matters when it changes Scribe Therapeutics Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest SCTX filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
8-KMaterial company eventFiled 2026-07-27 · Period 2026-07-27SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-08-03SEC ↗SCHEDULE 13DOfficial SEC filingFiled 2026-07-30SEC ↗SCHEDULE 13DOfficial SEC filingFiled 2026-07-30SEC ↗4Official SEC filingFiled 2026-07-29 · Period 2026-07-27SEC ↗4Official SEC filingFiled 2026-07-29 · Period 2026-07-23SEC ↗4Official SEC filingFiled 2026-07-29 · Period 2026-07-27SEC ↗SCHEDULE 13DOfficial SEC filingFiled 2026-07-29SEC ↗
Scribe Therapeutics Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →